MedPath

Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults

Not Applicable
Conditions
Acquired chronic pure red cell aplasia
Registration Number
JPRN-UMIN000024807
Lead Sponsor
Shinshu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Acute pure red cell aplasia, congenital pure red cell aplasia

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
Response rate of immunosuppressive therapy, efficacy of iron-chelation therapy in transfusion-dependent patients
© Copyright 2025. All Rights Reserved by MedPath